David Béchard
Founder at Cytune Pharma SAS
David Béchard active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Chairman | 2007-12-17 | - |
| Founder | 2007-11-14 | - | |
| Chief Operating Officer | 2007-11-14 | - | |
| President | 2007-11-14 | - |
Career history of David Béchard
Former positions of David Béchard
| Companies | Position | Start | End |
|---|---|---|---|
| Atlanpole Biotherapy | Corporate Officer/Principal | - | - |
Endotis Pharma SARL
 Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Endotis Pharma SARL is a holding company, which is engaged in the development of differentiated cardiovascular therapeutics based on validated targets and modes of action. The company was founded in 2003 and it is headquartered in Romainville, France. | Chairman | 2003-01-31 | - |
| Founder | 2003-01-31 | - | |
| President | 2003-01-31 | - |
Training of David Béchard
| École des Hautes Études Commerciales de Paris | Graduate Degree |
Statistics
International
| France | 5 |
Operational
| Chairman | 2 |
| Founder | 2 |
| President | 2 |
Sectoral
| Health Technology | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Endotis Pharma SARL
Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Endotis Pharma SARL is a holding company, which is engaged in the development of differentiated cardiovascular therapeutics based on validated targets and modes of action. The company was founded in 2003 and it is headquartered in Romainville, France. | Health Technology |
Cytune Pharma SAS
Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Commercial Services |
| Atlanpole Biotherapy |
- Stock Market
- Insiders
- David Béchard
- Experience
